Insider Buy/Sell Details for the Biotechnology Industry — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1194)
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
3,419
Price
$574.76
Total Value
$1.97M
Shares Held After
21,268
% of Holdings
13.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,456
Price
$574.04
Total Value
$1.41M
Shares Held After
24,687
% of Holdings
9.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
970
Price
$572.78
Total Value
$555.60K
Shares Held After
27,143
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
603
Price
$571.53
Total Value
$344.63K
Shares Held After
28,113
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
80
Price
$570.52
Total Value
$45.64K
Shares Held After
28,716
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
80
Price
$568.74
Total Value
$45.50K
Shares Held After
28,796
% of Holdings
0.3%
PTC THERAPEUTICS, INC. (PTCT)
Klein Matthew B. — Director
Shares
2,572
Price
$72.46
Total Value
$186.37K
Shares Held After
393,998
% of Holdings
0.6%
PTC THERAPEUTICS, INC. (PTCT)
Klein Matthew B. — Director
Shares
2,100
Price
$73.08
Total Value
$153.47K
Shares Held After
396,570
% of Holdings
0.5%
PTC THERAPEUTICS, INC. (PTCT)
Klein Matthew B. — Director
Shares
7,221
Price
$73.08
Total Value
$527.71K
Shares Held After
398,670
% of Holdings
1.8%
PTC THERAPEUTICS, INC. (PTCT)
Klein Matthew B. — Director
Shares
679
Price
$73.06
Total Value
$49.61K
Shares Held After
405,891
% of Holdings
0.2%
Royalty Pharma plc (RPRX)
Norden Gregory — Director
Shares
3,045
Price
$53.00
Total Value
$161.38K
Shares Held After
191,803
% of Holdings
1.6%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
50,000
Price
$20.09
Total Value
$1.00M
Shares Held After
1,122,626
% of Holdings
4.3%
Zai Lab Ltd (ZLAB)
Edmondson Frazor Titus III — Chief Legal Officer
Shares
3,517
Price
$20.19
Total Value
$71.01K
Shares Held After
19,849
% of Holdings
15.1%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research & Investments
Shares
13,684
Price
$53.06
Total Value
$726.14K
Shares Held After
31,881
% of Holdings
30.0%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
17,717
Price
$12.86
Total Value
$227.84K
Shares Held After
195,178
% of Holdings
8.3%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$77.92
Total Value
$584.40K
Shares Held After
400,330
% of Holdings
1.8%
Adlai Nortye Ltd. (ANL)
LU YANG — Director
Shares
10
Price
$13.18
Total Value
$131.80
Shares Held After
99,990
% of Holdings
0.0%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
75,178
Price
$14.00
Total Value
$1.05M
Shares Held After
909,843
% of Holdings
8.3%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
4,081
Price
$13.80
Total Value
$56.31K
Shares Held After
834,665
% of Holdings
0.5%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
1,341
Price
$82.58
Total Value
$110.74K
Shares Held After
1,115,987
% of Holdings
0.1%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
18,659
Price
$82.05
Total Value
$1.53M
Shares Held After
1,117,328
% of Holdings
1.6%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$56.29
Total Value
$1.41M
Shares Held After
1,248,095
% of Holdings
2.0%
INSMED Inc (INSM)
Bonstein Sara — Chief Financial Officer
Shares
8,272
Price
$116.18
Total Value
$961.04K
Shares Held After
71,486
% of Holdings
10.4%
INSMED Inc (INSM)
Lewis William — Director
Shares
13,283
Price
$116.18
Total Value
$1.54M
Shares Held After
287,902
% of Holdings
4.4%
Vericel Corp (VCEL)
MCLAUGHLIN KEVIN F — Director
Shares
3,500
Price
$32.82
Total Value
$114.87K
Shares Held After
18,300
% of Holdings
16.1%
Vericel Corp (VCEL)
MCLAUGHLIN KEVIN F — Director
Shares
3,500
Price
$32.83
Total Value
$114.91K
Shares Held After
18,300
% of Holdings
16.1%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
3,384
Price
$116.18
Total Value
$393.15K
Shares Held After
75,389
% of Holdings
4.3%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
4,470
Price
$112.76
Total Value
$504.04K
Shares Held After
78,773
% of Holdings
5.4%
INSMED Inc (INSM)
Smith Michael Alexander — Chief Legal Officer
Shares
4,109
Price
$116.18
Total Value
$477.38K
Shares Held After
47,762
% of Holdings
7.9%
BIOCRYST PHARMACEUTICALS INC (BCRX)
Barnes Alane P — Chief Legal Officer
Shares
62,500
Price
$9.54
Total Value
$596.25K
Shares Held After
400,703
% of Holdings
13.5%
INSMED Inc (INSM)
Adsett Roger — Chief Operating Officer
Shares
5,837
Price
$116.18
Total Value
$678.14K
Shares Held After
100,973
% of Holdings
5.5%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
1,316
Price
$78.01
Total Value
$102.67K
Shares Held After
242,662
% of Holdings
0.5%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
332
Price
$310.72
Total Value
$103.16K
Shares Held After
0
% of Holdings
100.0%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
33,769
Price
$20.22
Total Value
$682.89K
Shares Held After
1,122,626
% of Holdings
2.9%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
16,231
Price
$19.44
Total Value
$315.58K
Shares Held After
1,156,395
% of Holdings
1.4%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
1,575
Price
$223.50
Total Value
$352.01K
Shares Held After
41,786
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$583.81
Total Value
$210.17K
Shares Held After
40,513
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$582.32
Total Value
$46.59K
Shares Held After
40,873
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
371
Price
$581.52
Total Value
$215.74K
Shares Held After
40,953
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,494
Price
$580.50
Total Value
$867.27K
Shares Held After
41,324
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,752
Price
$579.58
Total Value
$1.02M
Shares Held After
42,818
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,874
Price
$578.63
Total Value
$1.08M
Shares Held After
44,570
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,567
Price
$577.58
Total Value
$905.07K
Shares Held After
46,444
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
624
Price
$576.34
Total Value
$359.64K
Shares Held After
48,011
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,378
Price
$575.40
Total Value
$792.90K
Shares Held After
48,635
% of Holdings
2.8%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
1,937
Price
$66.87
Total Value
$129.53K
Shares Held After
488,437
% of Holdings
0.4%
Dyne Therapeutics, Inc. (DYN)
Kerr Douglas — Chief Medical Officer
Shares
1,564
Price
$18.36
Total Value
$28.72K
Shares Held After
170,042
% of Holdings
0.9%
Dyne Therapeutics, Inc. (DYN)
Lucera Erick — Chief Financial Officer
Shares
1,448
Price
$18.36
Total Value
$26.59K
Shares Held After
123,925
% of Holdings
1.2%
Dyne Therapeutics, Inc. (DYN)
Cox John — Director
Shares
3,311
Price
$18.36
Total Value
$60.79K
Shares Held After
370,834
% of Holdings
0.9%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Militello John — Vice President of Finance, Treasurer, Principal Accounting Officer
Shares
855
Price
$3.61
Total Value
$3.08K
Shares Held After
90,164
% of Holdings
0.9%
Showing 301–350 of 1194 transactions (page 7 of 24)